Schedule 13D ownership disclosure
SELLAS Life Sciences Group, Inc.
Security class unavailable · CUSIP: 81642T100
Event date: 2018-07-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 22.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-18-223824
- Form type
- SC 13D
- Filer
- Equilibria Capital Management Ltd
- CIK
- CIK 1724701
- Filed
- Jul 23, 2018
- Reporting period
- Jul 16, 2018
- Description
- Schedule 13D beneficial ownership